(HealthDay)—U.S. officials need to take action to control spiking insulin prices, the American Medical Association (AMA) says. The Federal Trade Commission and the Justice Department should monitor insulin pricing and market competition and take any necessary enforcement measures, AMA members agreed at the group’s annual meeting. The nation’s largest physicians group said the rising cost of insulin is causing big […]